Scott Peters (D-Calif.) that progressives have resisted, saying they would rather leave drug pricing out of the package altogether than pass what they see as a weak version that will sap motivation for future action.
Biden previously cut a limited deal with Sinema and Rep. What’s next: No deal was final as of Sunday, but there was some hope in the party of clinching one within the next 24 to 48 hours, Burgess, Alice and Heather write.īut the same problems exist. It’s not as expansive as the House’s landmark HR 3 drug bill, but based on the same parameters. What’s in play: The latest draft effort includes a redesign of Medicare Part D, drug negotiation and rebates, said a source with direct knowledge of the effort. Chris Murphy (D-Conn.), Elizabeth Warren (D-Mass.), Bernie Sanders (I-Vt.), Amy Klobuchar (D-Minn.) and Mark Kelly (D-Ariz.) have discussed the matter all weekend and “much progress” has been made, said one source familiar, who added there is “optimism that something can be added before House votes.”
Party leaders have redoubled their efforts after drug pricing reform was dropped from last week’s draft spending proposal, dealing a blow to many Democrats who have pledged action to lower drug costs, a broad priority for voters. The conversations involve a group of Senate Democrats, including Kyrsten Sinema of Arizona, along with House leadership and rank-and-file and the White House, sources familiar with the effort told Burgess Everett, Alice Miranda Ollstein and Heather Caygle. Driving the DayĭEMOCRATS RACE FOR DRUG PRICING DEAL - Democrats are zeroing in on a deal to lower prescription drug prices that the party hopes it could add to President Joe Biden’s $1.75 trillion social spending bill as soon as today. At a time when the science has never been more promising, the Democrats’ latest drug pricing scheme puts patients in harm’s way by threatening future treatments and cures.
0 kommentar(er)
